Quinolinic acid and sigma receptor ligand: Effect on pyramidal neurons of the CA1 sector of dorsal hippocampus following peripheral administration in rats

Folia Neuropathologica

Volumn 36, Issue 2, 1998, Pages 94-100

  Beskid, Mirosław ^a   Rózycka, Zofia ^a   Taraszewska, Anna ^b  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Hippocampus; NMDA receptor; Pentazocine; Quinolinic acid; Sigma receptor

Indexed keywords

CALCIUM CHANNEL; LIGAND; N METHYLASPARTIC ACID; NARCOTIC ANALGESIC AGENT; PENTAZOCINE; QUINOLINIC ACID; SIGMA OPIATE RECEPTOR;

ANIMAL; ARTICLE; HIPPOCAMPUS; MALE; METABOLISM; PYRAMIDAL NERVE CELL; RAT; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; CALCIUM CHANNELS; HIPPOCAMPUS; LIGANDS; MALE; N-METHYLASPARTATE; PENTAZOCINE; PYRAMIDAL CELLS; QUINOLINIC ACID; RATS; RATS, WISTAR; RECEPTORS, SIGMA;

EID: 0032247589     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Albers GW, Goldberg MP, Choi DW: N-methyl-d-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol, 1989, 25, 398-403.
2. Bergeron R, de-Montigny C, Debonnel G: Biphasic effects of sigma ligands on the neuronal reponse to N-methyl-D-aspartate. Naunyn, Schmiedebergs, Arch Pharmacol, 1995, 351, 252-260.
3. Beskid M, Markiewicz D,: Morphological changes in the brain of rats after intracardiac and intraperitoneal administration of quinolinic acid. Neuropatol Pol, 1988, 26, 61-68.
4. Beskid M, Różycka Z: The effect of quinolinic acid administered during pregnancy on the hippocampal formation of rat's offspring (ultrastuctural investigation). Mater Med Pol, 1994, 26, 133-138.
5. Beskid M, Bialek J, Różycka Z: Quinolinic acid: effect on neurons of the paraventricular nucleus of the hypothalamus. Mater Med Pol, 1996, 28, 149-153.
6. Beskid M, Jachimowicz J, Taraszewska A: The effect of quinolinic acid administered during pregnancy on the nitrostriatal complex of rat's offspring: ultrastructural investigation. Exp Toxic Pathol, 1995, 47, 479-484.
7. Bhosale BB, Balsara JJ, Jadhav JH: Involvement of dopaminergic mechanism in racemic pentazocine induced stereotyped behaviour in rats. Indian J Physiol, 1996, 40, 271-273.
8. Choi DW: Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. TINS 1988, 11, 465-469.
9. Cotman CW, Monaghan DT, Otterson OP, Storm-Mathisen J: Anatomical organization of excitatory amino acids receptors and their pathway. Trends Neurosci, 1987, 10, 273-279.
10. Debonnel G, Bergeron R, Monnet FP, De Montigny C: Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning. Neurosci, 1996, 71, 977-987.
11. De Costa BR, Bowen WD, Hellewell SB, Walker JM, Thurkauf A, Jacobson AE, Rice KC: Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective ligand for sigma receptors. FEBS Lett, 1989, 251, 53-58.
12. Gonzales-Alvear GM, Werling LL: Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands. J Pharmacol Exp Ther, 1994, 271, 212-219.
13. Greenamyre JT, Olson JMM, Penney JB, Young AB: Autoradiographic characterization of N-methyl-D-aspartate, quisqualate- and kainate-sensitive glutamate binding sites. J Pharmacol Exp Ther, 1985, 233, 254-263.
14. Jarrad LE, Meldrum BS: Selective excitotxic pathology in the rat hippocampus. Neuropathol Appl Neurobiol, 1993, 19, 381-389.
15. Kaiser C, Pontecorvo MJ, Mewshaw RE: Sigma receptor ligand: function and activity. Neurotransmissions, 1991, 7, 1-5.
16. Kida E, Matyja E: Dynamics and pattern of ultrastructural alterations induced by quinolinic acid in organotypic culture of rat hippocampus. Neuropatol Pol, 1990, 28, 67-82.
17. Lockhart BP, Soulard P, Benicourt C, Privat A, Junien JL: Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res, 1995, 675, 110-120.
18. McDonald JW, Johnston MV: Excitatory amino acid neurotoxicity in the developing brain. In: Sigma, PCP, and NMDA Receptors. Res Monograph 133 U.S. Department of Health and Human Services Public Health Service. Substance Abuse and Mental Health Services Administration. National Institute on Drug Abuse 5600 Fishers Lane Rockville 1993, pp 185-205.
19. Rothman SM, Olney JW: Excitotoxicity and the NMDA receptor. TINS 1987, 10, 299-302.
20. Rothman SM, Thurston JH, Hauhart RE: Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience, 1987, 22, 471-480.
21. Scatton B: The NMDA receptor complex. Fundam Clin Pharnacol, 1993, 7, 389-400.
22. Schwarcz R, Whetsell WO Jr, Mangano RM: Quinolinic acid: an endogenous metabolite that produces axon-sparing lesion in rat brain. Science, 1983, 219, 316-318.
23. Schwarcz R, Brush GS, Foster AC, French ED: Seizure activity and lesions after intrahippocampal quinolinic acid injection. Exp Neurol, 1984, 34, 1-17.
24. Shukla VK, Lemaire S: Norbinaltorphimine protection against N-methyl-D-aspartic acid-induced convulsions and mortality. Eur J Pharmacol, 1993, 231, 293-296.
25. Singh L, Wong EH, Kesingland AC, Tricklenbank MD: Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10, 047). Br J Pharmacol, 1990, 99, 145-151.
26. Stone TW, Connick JH, Winn P, Hastings MH, English M: Endogenous excitoxic agents. In: Selective neuronal death. G Bock, M O'Connor (eds), Ciba Found Symp 126, Wiley J, Chochester 1987, pp 204-214.
27. Taraszewska A, Zelman IB, Szmielew A: Development of selective neuronal loss in the rat hippocampus after injection of quinolinic acid. Light- and electron microscopic studies. Neuropatol Pol, 1991, 29, 157-170.
28. Terman GW, Wagner JJ, Chavkin C: Kappa opioids inhibit induction of longterm potentation in the dentate gyrus of the guinea pig hippocampus. J Neurosci, 1994, 14, 4740-4747.
29. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KS: Sigma receptors: biology and function. Pharmacol Rev, 1990, 42, 355-402.
30. Wolfe Jr SA, Culp SG, Souza EB: Sigma-receptors on endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. Endocrinology, 1989, 124, 1160-1172.
31. Yamamoto H, Yamamoto T, Sagi N, Klenerova V, Goji K, Kawai N, Baba A, Takamori, Moroji T: Sigma ligands indirectly modulate the NMDA receptor-ion channels complex on intact neuronal cells via sigma 1 site. J Neurosci, 1995, 15, 731-736.